Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.157,76
0,23%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Dare Bioscience Inc (DARE) Dare Bioscience Inc (DARE) Notizie

Dare Bioscience Inc

DARE
0,4273
-0,0081 (-1,86%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/6/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:05EDGAR2Form 8-K - Current report
14/5/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202414:05EDGAR2Form 8-K - Current report
14/5/202414:00GLOBEDaré Bioscience Reports First Quarter 2024 Financial Results..
13/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
10/5/202422:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/5/202414:00GLOBEDaré Bioscience to Host First Quarter 2024 Financial Results..
02/5/202414:00GLOBEDaré Bioscience Selected as a Member of ARPA-H Investor..
30/4/202413:30GLOBEDaré Bioscience Secures $22 Million in Non-Dilutive..
23/4/202414:00GLOBEDaré Bioscience Announces Grant Funding Installment to..
11/4/202414:00GLOBEDaré Bioscience Announces Publication in Contraception of..
28/3/202413:00GLOBEDaré Bioscience Reports Full Year 2023 Financial Results and..
28/3/202412:42IHMARKETNEWSUS Stock Futures Stable in Pre-Market On Path for..
21/3/202413:00GLOBEDaré Bioscience to Host Full Year 2023 Financial Results and..
22/2/202414:00GLOBEDaré Bioscience to Present at the International Society for..
31/1/202414:00GLOBEDaré Bioscience Announces Positive End-of-Phase 2 Meeting..
26/1/202423:15EDGAR2Form 8-K - Current report
26/1/202422:30GLOBEDaré Bioscience Announces Executive Team and Board of..
19/1/202422:30EDGAR2Form 8-K - Current report
17/1/202414:00GLOBEDaré Bioscience Announces Grant to Support Biotherapeutic..
08/1/202414:00EDGAR2Form 8-K - Current report
04/1/202414:00GLOBEDaré Bioscience’s DARE-LARC1 Platform Technology Achieves..
26/12/202314:05EDGAR2Form 8-K - Current report
26/12/202314:00GLOBEDaré Bioscience Secures $12 million in Royalty-backed..
20/12/202314:05EDGAR2Form 8-K - Current report
20/12/202314:00GLOBEDaré Bioscience Announces Positive Topline Pharmacokinetic..
13/12/202314:00GLOBEDaré Bioscience Announces Funding Award Notice from the..
07/12/202314:00GLOBEDaré Bioscience Announces FDA Clearance of Investigational..
04/12/202314:00GLOBEDaré Bioscience Announces Commencement of Phase 3 Study of..
20/11/202314:00GLOBEDaré Bioscience and Premier Research Extend Strategic..
13/11/202314:00GLOBEDaré Bioscience to Present at the Sexual Medicine Society of..
09/11/202323:15EDGAR2Form 8-K - Current report
09/11/202322:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202314:05EDGAR2Form 8-K - Current report
09/11/202314:00GLOBEDaré Bioscience Reports Third Quarter 2023 Financial Results..
06/11/202314:00GLOBEDaré Bioscience to Participate in Three November Conferences
02/11/202313:00GLOBEDaré Bioscience to Host Third Quarter 2023 Financial Results..
01/11/202313:05EDGAR2Form 8-K - Current report
01/11/202313:00GLOBEDaré Bioscience Announces Additional Positive Data from..
16/10/202314:15EDGAR2Form 8-K - Current report
16/10/202314:00GLOBEDaré Bioscience Announces Achievement of First Commercial..
21/9/202314:00GLOBEDaré Bioscience Announces Grant Funding Installment to..
20/9/202314:00GLOBEDaré Bioscience to Present at The Menopause Society 2023..
11/9/202314:15EDGAR2Form 8-K - Current report
06/9/202314:00GLOBEDaré Bioscience to Participate in Upcoming Investor..
05/9/202314:00GLOBEDaré Bioscience Completes Previously Announced Equity..
30/8/202323:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
Apertura: 0,44 Min: 0,4211 Max: 0,4548
Chiusura: 0,4354

La tua Cronologia

NASDAQ
DARE
Dare Bioscience
BTRX
ICAUSDT
Icarus
USOTC
BMIX
Brazil Minerals (QB)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network